Clinical Significance of Hepatitis and its Types - A Review
DOI:
https://doi.org/10.31580/pjmls.v7i4.3119Keywords:
Hepatitis, Organism, Pathogenic, World WideAbstract
Hepatitis is a liver inflammation caused by a pathogenic virus. Viral infections of the liver have had a profound influence on humanity, causing severe morbidity and mortality in people with acute and chronic infections. The prognosis for hepatocellular carcinoma (HCC), a highly aggressive condition, is incredibly bad. It is a serious malignancy that kills about a million people worldwide each year. The discovery of viral agents increased scientific interest in determining the pathogenesis and diagnostic methods for identifying the infected population, which was previously unknown. With fast scientific and technological breakthroughs in recent decades, managing and even curing diseases became possible, with a strong emphasis on preventive care through vaccination. As a result, primary care physicians and gastroenterologists must have a thorough understanding of hepatitis A, B, C, D, and E before providing care to these patients. The review article addresses epidemiology, etiology, clinical presentation, diagnostic techniques, and current medication treatments, with an emphasis on future therapy options and the importance of liver transplants.
Each hepatitis virus, Hepatitis A, B, C, D, E, and G, presents a unique scenario to the patient and practitioner alike. Since the discovery of each virus, a wealth of information on epidemiology, virologic properties, and the natural clinical and immunologic history of acute and chronic infections has emerged. Basic insights concerning host immune responses to acute and chronic viral infections, along with virologic data, have resulted in vaccines to prevent Hepatitis A, B, and E, as well as extremely effective antivirals for Hepatitis B and C. These therapeutic breakthroughs are changing the landscape of hepatology, transplant medicine in general, and public and global health. Most importantly, there is a concerted global effort to eradicate chronic viral hepatitis within the decade.
References
Butt AA, Yan P, Shaikh OS, Abou‐Samra AB. Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES. Alimentary pharmacology & therapeutics. 2018;47(3):412-20.
Hepatitis, World health Organization (WHO)
Koff RS. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness. Journal of hepatology. 2002;37(1):2-6.
Melnick JL. Properties and classification of hepatitis A virus. Vaccine. 1992;10:S24-6.
World Health Organization. Hepatitis A. [cited 19 January 2021] Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-a
Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiologic reviews. 2006 ;28(1):101-11.
Foster MA. Increase in hepatitis A virus infections—United States, 2013–2018. MMWR. Morbidity and mortality weekly report. 2019;68(18): 413-415.
Cooksley WG. What did we learn from the Shanghai hepatitis A epidemic?. Journal of viral hepatitis. 2000;7:1-3.
Halliday ML, Kang LY, Zhou TK, Hu MD, Pan QC, Fu TY, Huang YS, Hu SL. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. Journal of Infectious Diseases. 1991;164(5):852-9.
Foster M. Hepatitis A virus outbreaks associated with drug use and homelessness—California, Kentucky, Michigan, and Utah, 2017. MMWR. Morbidity and mortality weekly report. 2018;67(43);1208-1210.
Severi E, Tavoschi L, Carrillo-Santisteve P, Westrell T, Marrone G, Giesecke J, Lopalco P. Hepatitis A notifications in the EU/EEA, 2010–2019: what can we learn from case reporting to the European Surveillance System?. Eurosurveillance. 2023;28(19):2200575..
Manka P, Verheyen J, Gerken G, Canbay A. Liver failure due to acute viral hepatitis (AE). Visceral medicine. 2016;32(2):80-5.
Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Journal of clinical & laboratory immunology. 1993;40(2):47-60.
Fleischer B, Fleischer S, Maier K, Wiedmann KH, Sacher M, Thaler H, Vallbracht A. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology. 1990;69(1):14.
Vallbracht A, Fleischer B, Busch FW. Hepatitis A: hepatotropism and influence on myelopoiesis. Intervirology. 1993;35(1-4):133-9.
Mac kinney-Novelo I, Barahona-Garrido J, Castillo-Albarran F, Santiago-Hernández JJ, Méndez-Sánchez N, Uribe M, Chávez-Tapia N. Clinical course and management of acute hepatitis A infection in adults. Annals of hepatology. 2015;11(5):652-7.
GORDON SC, REDDY KR, SCHIFF L, SCHIFF ER. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Annals of internal medicine. 1984;101(5):635-7.
Matheny SC, Kingery JE. Hepatitis a. American family physician. 2012;86(11):1027-34.
Arrospide MT, Barúa RL. Viral hepatitis A as a triggering agent of autoimmune hepatitis report of a case and review of literature. Revista de gastroenterologia del Peru: organo oficial de la Sociedad de Gastroenterologia del Peru. 2003;23(2):134-7.
Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World journal of gastroenterology. 2021;27(16):1691.
Liaw YF, Yang CY, Chu CM, Huang MJ. Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection. 1986;14(4):156-8.
Lemon SM, Binn LN, Marchwicki R, Murphy PC, Ping LH, Jansen RW, Asher LV, Stapleton JT, Taylor DG, LeDuc JW. In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus. Journal of Infectious Diseases. 1990;161(1):7-13.
Centers for Disease Control and Prevention (CDC. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR. Morbidity and mortality weekly report. 2005;54(18):453-6.
You H, Wang X, Ma L, Zhang F, Zhang H, Wang Y, Pan X, Zheng K, Kong F, Tang R. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Communication and Signaling. 2023;21(1):70.
Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World journal of clinical cases. 2018;6(13):589.
Abdullah S, Zahoor S, Rao MA, Abdullah SM, Asif S, Wajid A, Zaidi AR. Seroprevalence of hepatitis B virus in blood donors at a large teaching hospital of Pakistan: a potential health policy concern. Journal of Applied Hematology. 2019;10(1):29-32.
Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72(5):1605-16.
Velkov S, Ott JJ, Protzer U, Michler T. The global hepatitis B virus genotype distribution approximated from available genotyping data. Genes. 2018;9(10):495.
Meireles LC, Marinho RT, Van Damme P. Three decades of hepatitis B control with vaccination. World journal of hepatology. 2015;7(18):2127.
Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood, The Journal of the American Society of Hematology. 2019;133(17):1854-64.
Jafari S, Buxton JA, Afshar K, Copes R, Baharlou S. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Canadian journal of public health. 2012;103:207-12.
Bixler D, Annambholta P, Abara WE, Collier MG, Jones J, Mixson-Hayden T, Basavaraju SV, Ramachandran S, Kamili S, Moorman A. Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017. American Journal of Transplantation. 2019;19(9):2570-82.
Scaglioni PP, Melegari M, Wands JR. Recent advances in the molecular biology of hepatitis B virus. Bailliere's clinical gastroenterology. 1996;10(2):207-25.
Rybicka M, Bielawski KP. Recent advances in understanding, diagnosing, and treating hepatitis B virus infection. Microorganisms. 2020;8(9):1416.
Revill PA, Tu T, Netter HJ, Yuen LK, Locarnini SA, Littlejohn M. The evolution and clinical impact of hepatitis B virus genome diversity. Nature Reviews Gastroenterology & Hepatology. 2020;17(10):618-34.
Jindal A, Kumar M, Sarin SK. Management of acute hepatitis B and reactivation of hepatitis B. Liver international. 2013;33:164-75.
Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. Journal of viral hepatitis. 2007;14(3):147-52.
Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis. World journal of gastroenterology: WJG. 2012;18(24):3119.
Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. Journal of hepatology. 2014;61(6):1407-17.
Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship. World journal of gastroenterology: WJG. 2014;20(30):10395.
Prasidthrathsint K, Stapleton JT. Laboratory diagnosis and monitoring of viral hepatitis. Gastroenterology Clinics. 2019;48(2):259-79.
Jeng WJ, Lok AS. Should treatment indications for chronic hepatitis B be expanded?. Clinical Gastroenterology and Hepatology. 2021;19(10):2006-14.
Tao Y, Wu D, Zhou L, Chen E, Liu C, Tang X, Jiang W, Han N, Li H, Tang H. Present and future therapies for chronic hepatitis B. Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs. 2020:137-86.
Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown Jr RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-99.
Shi G, Suzuki T. Molecular basis of encapsidation of hepatitis C virus genome. Frontiers in microbiology. 2018;9:396.
Chemaitelly H, Mahmud S, Kouyoumjian SP, Al‐Kanaani Z, Hermez JG, Abu‐Raddad LJ. Who to test for hepatitis C virus in the Middle East and North Africa?: pooled analyses of 2,500 prevalence measures, including 49 million tests. Hepatology Communications. 2019;3(3):325-39.
Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318-27.
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of hepatology. 2014;61(1):S45-57.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013 ;57(4):1333-42.
Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology. 2000;31(3):756-62.
Irshad M, Mankotia DS, Irshad K. An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World journal of gastroenterology: WJG. 2013;19(44):7896.
Zeisel MB, Felmlee DJ, Baumert TF. Hepatitis C virus entry. Hepatitis C virus: from molecular virology to antiviral therapy. 2013:87-112.
Zein NN. Clinical significance of hepatitis C virus genotypes. Clinical microbiology reviews. 2000;13(2):223-35.
Clément S, Pascarella S, Negro F. Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress. Viruses. 2009;1(2):126-43.
Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE, Pircher H, Thimme R. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS pathogens. 2010;6(6):e1000947.
Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado JA, Salido GM, Gonzalez-Gallego J. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. Journal of Hepatology. 2009;50(5):872-82.
Westbrook RH, Dusheiko G. Natural history of hepatitis C. Journal of hepatology. 2014;61(1):S58-68.
Evon DM, Stewart PW, Amador J, Serper M, Lok AS, Sterling RK, Sarkar S, Golin CE, Reeve BB, Nelson DR, Reau N. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PloS one. 2018;13(8):e0196908.
Nazeer S, Iqbal A, Baloch MC, Khan B, Ismail M, Iqbal B, Naseem M. Prevalence, Risk Factors, and Associated Sub-Clinical Aspects of Hepatitis A, B And C in Ethnic Groups of Panjgur District, Balochistan. Pak-Euro Journal of Medical and Life Sciences. 2023;6(2):55-62.
Mosley JW, Operskalski EA, Tobler LH, Andrews WW, Phelps B, Dockter J, Giachetti C, Busch MP. Viral and host factors in early hepatitis C virus infection. Hepatology. 2005;42(1):86-92.
Marcellin P. Hepatitis C: the clinical spectrum of the disease. Journal of hepatology. 1999;31:9-16.
Chu CM, Yeh CT, Liaw YF. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut. 1999;45(4):613-7.
Alborino F, Burighel A, Tiller FW, Van Helden J, Gabriel C, Raineri A, Catapano R, Stekel H. Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity. Medical microbiology and immunology. 2011;200:77-83.
Cobb B, Pockros PJ, Vilchez RA, Vierling JM. HCV RNA viral load assessments in the era of direct-acting antivirals. Official journal of the American College of Gastroenterology| ACG. 2013 ;108(4):471-5.
Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, Manns MP, Tillmann HL. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. Journal of clinical virology. 2009;46(3):210-5.
Doshi RK, Ruben M, Drezner K, Lachmann A, Kuo I, Chanes-Mora P, Varga L, Saafir-Callaway B, Visconti A, Kharfen M. Knowledge, attitudes, and behaviors related to hepatitis C screening and treatment among health care providers in Washington, DC. Journal of Community Health. 2020;45:785-94.
Kucirka LM, Farzadegan H, Feld JJ, Mehta SH, Winters M, Glenn JS, Kirk GD, Segev DL, Nelson KE, Marks M, Heller T. Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. The Journal of infectious diseases. 2010;202(6):845-52.
Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997-1003.
Rizzetto M, Smedile A. Pegylated interferon therapy of chronic hepatitis D: in need of revision. Hepatology. 2015;61(4):1109-11.
Ponzetto A, Hoyer BH, Popper H, Engle R, Purcell RH, Gerin JL. Titration of the infectivity of hepatitis D virus in chimpanzees. Journal of Infectious Diseases. 1987;155(1):72-8.
Govindarajan S, de Cock KM, Redeker AG. Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology. 1986;6(4):640-4.
Khan B, Iqbal A, Baloch MC, Ismail M, Nasir S, Iqbal B, Naseem M. Screening of Risk Factors and Subclinical Aspects for Hepatitis A, B and C in the Hospitalized Drug Addictives in “Treatment And Rehabilitation Center” in District Kech, Balochistan. Pak-Euro Journal of Medical and Life Sciences. 2023;6(2):77-84.
Smedile A, Dentico P, Zanetti A, Sagnelli E, Nordenfelt E, Actis GC, Rizzetto M. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology. 1981;81(6):992-7.
Bockmann JH, Grube M, Hamed V, von Felden J, Landahl J, Wehmeyer M, Giersch K, Hall MT, Murray JM, Dandri M, Lüth S. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort. BMC gastroenterology. 2020;20:1-6.
Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. The Journal of infectious diseases. 2009;200(1):48-56.
Cangin C, Focht B, Harris R, Strunk JA. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM. Journal of Medical Virology. 2019;91(1):124-31.
Xia J, Zeng H, Liu L, Zhang Y, Liu P, Geng J, Wang L, Wang L, Zhuang H. Swine and rabbits are the main reservoirs of hepatitis E virus in China: detection of HEV RNA in feces of farmed and wild animals. Archives of virology. 2015;160:2791-8.
Andonov A, Robbins M, Borlang J, Cao J, Hatchette T, Stueck A, Deschambault Y, Murnaghan K, Varga J, Johnston L. Rat hepatitis E virus linked to severe acute hepatitis in an immunocompetent patient. The Journal of infectious diseases. 2019;220(6):951-5.
Perumpail RB, Ahmed A, Higgins JP, So SK, Cochran JL, Drobeniuc J, Mixson-Hayden TR, Teo CG. Fatal accelerated cirrhosis after imported HEV genotype 4 infection. Emerging infectious diseases. 2015;21(9):1679.
Behrendt P, Steinmann E, Manns MP, Wedemeyer H. The impact of hepatitis E in the liver transplant setting. Journal of Hepatology. 2014;61(6):1418-29.
Aggarwal RA. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. InSeminars in liver disease. Thieme Medical Publishers. 2013;33 (01):030-040.
Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. The Lancet. 2010;376(9744):895-902.
Zahm SH, Ward MH. 1998. Pesticides and childhood cancer. Environ Health Perspect 106:893–908.
Zipf TF, Berg S, Roberts WM, Poplack DG, Steuber CP, Bleyer WA. 2000. Childhood leukemias. In: Clinical Oncology (Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds). 2nd ed. Philadelphia:Churchill Livingston, 2402–2429.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Pak-Euro Journal of Medical and Life Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
